New West Nile Virus Equine Recombinant DNA Vaccine Approved
Editor’s note: A letter to the editor from Fort Dodge Animal Health cited inaccuracies in this article and can be seen by clicking here.
A new West Nile virus (WNV) equine recombinant canarypox vaccine received USDA registration approval on Dec. 23, and could pave the way for a new generation of equine
- Topics: Article
Editor’s note: A letter to the editor from Fort Dodge Animal Health cited inaccuracies in this article and can be seen by clicking here.
A new West Nile virus (WNV) equine recombinant canarypox vaccine received USDA registration approval on Dec. 23, and could pave the way for a new generation of equine vaccines in the United States. Merial has been developing this Recombitek equine WNV technology for three years. The company assembled a group of researchers, clinicians, and private practitioners in New Orleans, La., on Nov. 19, 2003, to review WNV and the research behind the technology
Create a free account with TheHorse.com to view this content.
TheHorse.com is home to thousands of free articles about horse health care. In order to access some of our exclusive free content, you must be signed into TheHorse.com.
Start your free account today!
Already have an account?
and continue reading.
Related Articles
Stay on top of the most recent Horse Health news with
